Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis. Issue 7 (28th April 2018) - Caocci, Giovanni; Mulas, Olga; Annunziata, Mario; Luciano, Luigiana; Bonifacio, Massimiliano; Orlandi, Ester Maria; Pregno, Patrizia; Galimberti, Sara; Russo Rossi, Antonella; Abruzzese, Elisabetta; Iurlo, Alessandra; Martino, Bruno; et al.